SARS-CoV-2 mRNA vaccination induces an intranasal mucosal response characterized by neutralizing antibodies

BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA vaccine-induced systemic antibody profiles are well characterized; however, little is known about whether intranasal mucosal antibodies are induced or can neutralize virus in response to mRNA vaccination. OBJECTIVE: We sou...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Kevin T., Cobos-Uribe, Catalina, Knight, Noelle, Jonnalagadda, Rithika, Robinette, Carole, Jaspers, Ilona, Rebuli, Meghan E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290737/
https://www.ncbi.nlm.nih.gov/pubmed/37781659
http://dx.doi.org/10.1016/j.jacig.2023.100129

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290737/
https://www.ncbi.nlm.nih.gov/pubmed/37781659
http://dx.doi.org/10.1016/j.jacig.2023.100129

Ejemplares similares